Cryo-Cell International Inc
AMEX:CCEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cryo-Cell International Inc
Total Liabilities & Equity
Cryo-Cell International Inc
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cryo-Cell International Inc
AMEX:CCEL
|
Total Liabilities & Equity
$61.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Liabilities & Equity
$16.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Liabilities & Equity
$253.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Total Liabilities & Equity
$157.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Liabilities & Equity
$18.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Total Liabilities & Equity
$2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Cryo-Cell International Inc
Glance View
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.
See Also
What is Cryo-Cell International Inc's Total Liabilities & Equity?
Total Liabilities & Equity
61.7m
USD
Based on the financial report for Nov 30, 2025, Cryo-Cell International Inc's Total Liabilities & Equity amounts to 61.7m USD.
What is Cryo-Cell International Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
12%
Over the last year, the Total Liabilities & Equity growth was -5%. The average annual Total Liabilities & Equity growth rates for Cryo-Cell International Inc have been -2% over the past three years , 6% over the past five years , and 12% over the past ten years .
